Vahid SaadatFounder

United States - San Francisco Bay Area

Vahid Saadat is a serial medical device entrepreneur with 25 years of experience developing and commercializing medical products. Vahid currently runs Inquis Medical, Inc.. a medical device company in Redwood City, California. Previously, Vahid run Arrinex, Inc., a company developing a one time,office based therapy for chronic rhinitis. Arrinex was recently acquired by Stryker, Inc. Prior to Arrinex, Vahid served as the CEO of Voyage Medical, funded by Kleiner perkins, Three Arch , RWI and Abbott Ventures. Voyage Medical developed treatments for atrial fibrillation. Prior to Voyage Medical, Vahid co-founded Baxano, funded by Prospect ventures, Three Arch Partners and Kearney Ventures. Baxano is a spinal stenosis treatment company. Prior to Baxano, Vahid co-founded USGI medical, funded by Interwest partners, JJDC, and Alta Partners. USGI Medical is a commercial stage company specializing in the treatment of diseases through the natural passageways of the body. Prior to USGI, Mr. Saadat run AngioTrax, Funded by Onset Ventures, Delphi Ventures and IVP Capital. AngioTrax developed a technology for the treatment of end stage cardiac patients. Mr. Saadat holds a Bachelor's and Master’s degrees in engineering from the University of Texas at Austin. He is named an inventor on 200 patents in a variety of medical specialties.